ARGA Investment Management LP Has $1.48 Million Stake in Ambev S.A. $ABEV

Key Points

• ARGA Investment Management cut its stake in Ambev by 46.2% in Q4, selling 512,944 shares and ending the period with 597,022 shares valued at about $1.48 million.
• Insider De Lacerda Eduardo Cavalcanti sold 152,386 shares on March 27 at $2.85 for roughly $434,300, reducing his ownership by 40.56% to 223,340 shares (valued at ~$636,519).
• Analysts show a mixed outlook with a consensus rating of "Hold" (1 Buy, 4 Hold, 1 Sell) and an average target price of $2.84; shares trade around $2.90 with a 52-week range of $2.10–$3.24.

ARGA Investment Management LP cut its holdings in Ambev S.A. (NYSE:ABEV - Free Report) by 46.2% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 597,022 shares of the company's stock after selling 512,944 shares during the period. ARGA Investment Management LP's holdings in Ambev were worth $1,475,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Modern Wealth Management LLC acquired a new stake in shares of Ambev in the third quarter valued at approximately $25,000. Monument Capital Management acquired a new stake in shares of Ambev in the fourth quarter valued at approximately $25,000. First Trust Advisors LP acquired a new stake in shares of Ambev in the third quarter valued at approximately $25,000. Integrated Wealth Concepts LLC acquired a new stake in shares of Ambev in the first quarter valued at approximately $26,000. Finally, Bensler LLC acquired a new stake in shares of Ambev in the third quarter valued at approximately $27,000. 8.13% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Ambev news, insider De Lacerda Eduardo Cavalcanti sold 152,386 shares of the business's stock in a transaction that occurred on Friday, March 27th. The stock was sold at an average price of $2.85, for a total transaction of $434,300.10. Following the transaction, the insider owned 223,340 shares of the company's stock, valued at $636,519. The trade was a 40.56% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the company. Weiss Ratings raised Ambev from a "hold (c+)" rating to a "buy (b-)" rating in a research report on Thursday, March 5th. Barclays lifted their target price on Ambev from $2.50 to $3.00 and gave the company an "equal weight" rating in a research report on Tuesday, February 17th. Wall Street Zen downgraded Ambev from a "buy" rating to a "hold" rating in a research report on Monday, March 30th. Finally, UBS Group set a $2.65 target price on Ambev and gave the company a "sell" rating in a research report on Thursday, April 16th. One investment analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, Ambev presently has a consensus rating of "Hold" and an average target price of $2.84.

Ambev Price Performance

Shares of ABEV opened at $2.90 on Tuesday. The company has a market cap of $45.63 billion, a price-to-earnings ratio of 16.08, a PEG ratio of 2.07 and a beta of 0.66. Ambev S.A. has a 1-year low of $2.10 and a 1-year high of $3.24. The company's fifty day simple moving average is $2.99 and its 200 day simple moving average is $2.69. The company has a current ratio of 0.96, a quick ratio of 0.73 and a debt-to-equity ratio of 0.03.

Ambev (NYSE:ABEV - Get Free Report) last issued its earnings results on Friday, February 13th. The company reported $0.05 earnings per share for the quarter, hitting analysts' consensus estimates of $0.05. The business had revenue of $4.50 billion for the quarter, compared to the consensus estimate of $4.28 billion. Ambev had a net margin of 17.75% and a return on equity of 16.41%. On average, research analysts forecast that Ambev S.A. will post 0.19 earnings per share for the current fiscal year.

Ambev Company Profile

Ambev NYSE: ABEV is a Brazilian-based beverage company that produces, distributes and markets a broad portfolio of alcoholic and non-alcoholic drinks. The company's core business centers on brewing and selling beer, alongside a range of soft drinks, bottled water, energy drinks and other malt-based beverages. Headquartered in São Paulo, Ambev operates an integrated value chain that covers manufacturing, packaging, logistics and commercial sales to retail, on-premise and institutional customers.

The company traces its origins to the 1999 merger of two historic Brazilian breweries, and later became part of the broader global brewing group through subsequent industry consolidations.

Want to see what other hedge funds are holding ABEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ambev S.A. (NYSE:ABEV - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.